Cyclophilins in Atherosclerosis: A New Therapeutic Target?

Author(s): Michael Bukrinsky, Alexander Orekhov, Michael Ditiatkovski, Dmitri Sviridov

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 33 , 2013

Become EABM
Become Reviewer
Call for Editor


Atherosclerosis is a chronic disease with a significant inflammatory component. Recent studies indicate a role of extracellular cyclophilins as contributors to endothelial inflammation and pathogenesis of atherosclerosis. In this article, we review current literature on pro-inflammatory activities of extracellular cyclophilins and discuss possible approaches to selectively target this novel proinflammatory factor.

Keywords: Extracellular cyclophilins, chemotaxis, inflammation, CD147, leukocytes, monocytes.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Page: [5904 - 5908]
Pages: 5
DOI: 10.2174/1381612811319330009
Price: $65

Article Metrics

PDF: 20